Patent · US Active

Substituted quinoxalines, their preparation and their therapeutical use as 11βHSD1 modulators

US7947834B2 · kind B2 · utility

8Cited by

1References

13Claims

0Family size

Assignee

Sanofi-Aventis · FR

Inventors

Alain Braun · Antony, FR
Patrick Mougenot · Paris, FR
Claudie Namane · Paris, FR
Eric Nicolai · Paris, FR
Francois Pacquet · Paris, FR
Christophe Philippo · Rueil-Malmaison, FR
Olivier Venier · Poitiers, FR
Olivier Crespin · Paris, FR
Cecile Pascal · Paris, FR
Michel Aletru · Antony, FR
Stefan GUSSREGEN · Wiesbaden, DE

Key dates

Filing date	Dec 18, 2008
Grant date	May 24, 2011
Priority date	—
Expiry date	Dec 18, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is related to a compound of formula (I):wherein i, j, n, o, p, q, r, R1a, R1b, R1c, R1d, R2a, R2b, R2c, R2d, R3a, R3b and R4 are as defined herein, or an addition salt with an acid thereof, or a hydrate or solvate thereof, its preparation, pharmaceutical composition, and uses for treating a disease in which the enzyme 11β-HSD1 is involved.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.